WallStSmart
QTRX

Quanterix Corp

NASDAQ: QTRX · HEALTHCARE · MEDICAL DEVICES

$3.13
+2.62% today

Updated 2026-04-30

Market cap
$157.20M
P/E ratio
P/S ratio
1.13x
EPS (TTM)
$-2.51
Dividend yield
52W range
$3 – $9
Volume
0.9M

Quanterix Corp (QTRX) Financial statements

SEC filings — annual and quarterly data.

Income statement — annual

Item20152016201720182019202020212022202320242025
Revenue$12.18M$17.59M$22.87M$37.63M$56.73M$86.38M$110.56M$105.52M$121.14M$135.44M$138.90M
Revenue growth (YoY)+44.4%+30.1%+64.5%+50.8%+52.2%+28.0%-4.6%+14.8%+11.8%+2.6%
Cost of revenue$6.46M$9.84M$12.89M$19.65M$29.90M$38.20M$48.83M$60.16M$48.14M$54.32M$73.94M
Gross profit$5.71M$7.75M$9.99M$17.98M$26.84M$48.18M$61.73M$45.36M$73.00M$81.12M$64.96M
Gross margin46.9%44.1%43.7%47.8%47.3%55.8%55.8%43.0%60.3%59.9%46.8%
R&D$10.08M$16.99M$16.30M$15.29M$16.19M$20.17M$27.98M$26.81M$26.06M$31.08M$35.92M
SG&A$10.15M$12.47M$19.69M$33.78M$52.25M$59.59M$92.34M$91.55M$92.82M$104.64M$138.85M
Operating income$-14.52M$-21.71M$-26.00M$-31.55M$-41.60M$-31.58M$-58.59M$-104.26M$-45.99M$-52.62M$-87.42M
Operating margin-119.2%-123.5%-113.7%-83.8%-73.3%-36.6%-53.0%-98.8%-38.0%-38.8%-62.9%
EBITDA$-14.48M$-21.43M$-25.59M$-30.20M$-38.59M$-27.27M$-53.73M$-67.89M$-36.37M$-44.26M$-68.49M
EBITDA margin-118.9%-121.9%-111.9%-80.2%-68.0%-31.6%-48.6%-64.3%-30.0%-32.7%-49.3%
EBIT$-14.90M$-21.88M$-26.07M$-31.55M$-41.60M$-31.58M$-58.59M$-73.30M$-44.66M$-52.62M$-87.42M
Interest expense$1.04M$1.30M$952000.00$46000.00$627000.00$273000.00$403000.00$5.13M$15.84M
Income tax$660000.00$1.13M$408000.00$25000.00$-187000.00$-376000.00$-36000.00$164000.00$719000.00$434000.00
Effective tax rate-4.3%-5.1%-1.5%-0.1%0.5%1.2%0.1%-0.2%-2.6%-1.1%0.0%
Net income$-15.94M$-23.17M$-27.02M$-31.05M$-40.80M$-31.53M$-57.69M$-99.57M$-28.35M$-38.53M$-107.15M
Net income growth (YoY)-45.3%-16.6%-14.9%-31.4%+22.7%-83.0%-72.6%+71.5%-35.9%-178.1%
Profit margin-130.9%-131.8%-118.1%-82.5%-71.9%-36.5%-52.2%-94.4%-23.4%-28.4%-77.1%